PharmiWeb.com - Global Pharma News & Resources
15-Jun-2019

Biological Drugs Market 2019 Worldwide Growth, Trends and Forecasts (2019-2024)

Market Research Engine has published a new report titled as “Biological Drugs Market By Product (Therapeutic Protein, Monoclonal Antibody, Vaccine); By Application (Hospital, Clinics, Research centres) and by Regional Analysis - Global Forecast by 2018 – 2024.”

The Biological Drugs Market is expected to exceed more than US$ 394 Billion by 2024 at a CAGR of 10.3% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/biological-drugs-market

Report Scope:

The scope of the report includes a detailed study of Biological Drugs Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the  Market share and company profiles of the key participants operating in the global Market. Key players profiled in the report include Merck, Abbott Laboratories, Eli Lilly and Company, Baxter, Novartis, Pfizer, Biogen, Bristol-Myers Squibb Company, Amgen and GlaxoSmithKline. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 

Primary source of biological drugs is living cells. These medications are utilized in treatment and aversion of interminable sicknesses, for example, severe blood disorders, cancer and couple of other auto-invulnerable ailments. The mind-boggling structure of natural medications isolates them from other customary medication composes. Interest for organic medications has developed in later stage, which is credited to the expanding pervasiveness of constant illnesses over the globe.  

 

The Biological Drugs Market is segmented on the lines of its product, application and regional. On the basis of product segmentation, it covers Therapeutic Protein, Monoclonal Antibody and Vaccine. Based on application classification it includes Hospitals, Clinics and Research centres. The Biological Drugs Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic   Market is further segmented to provide   Market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Primary source of biological drugs is living cells. These medications are utilized in treatment and aversion of interminable sicknesses, for example, severe blood disorders, cancer and couple of other auto-invulnerable ailments. The mind-boggling structure of natural medications isolates them from other customary medication composes. Interest for organic medications has developed in later stage, which is credited to the expanding pervasiveness of constant illnesses over the globe.

The major driving factors of Biological Drugs Market are as follows:

  • Healthcare awareness initiatives taken by both public and private organizations
  • Growing geriatric population and higher prevalence of chronic diseases

The major restraining factors of Biological Drugs Market are as follows:

  • Severe side effects and associated risks from injectable biological drugs
  • Issues related to patent expiry of bestselling drugs and pricey nature

The major opportunities of Biological Drugs Market are as follows:

  • On-going R&D programs and innovation in biomedical technology

The Biological Drugs Market has been segmented as below:

By Product:

  • Therapeutic Protein
  • Monoclonal Antibody
  • Vaccine

By Application:

  • Hospital
  • Clinics
  • Research centres

 By Regional Analysis:

  •     North America
  •     Europe
  •     Asia-Pacific
  •     Rest of the World

This report provides:

1) An overview of the Global Market for Biological Drugs Market and related technologies.
2) Analyses of global   Market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new   Market opportunities and targeted promotional plans for Biological Drugs Market.

4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry. 

Reasons to Buy this Report:

  1. Obtain the most up to date information available on Biological Drugs Market.
  2. Identify growth segments and opportunities in the industry.
  3. Facilitate decision making on the basis of strong historic and forecast of Biological Drugs Market.
  4. Assess your competitor’s refining portfolio and its evolution.

Request Sample Report from here: https://www.marketresearchengine.com/biological-drugs-market

Table of Contents:

  1. Introduction
  2. Research Methodology
  3. Report Summary
  4. Market Overview

    4.1    Introduction

    4.2    Drivers

    4.3    Restrains

    4.4    Industry Trends

    4.5    Porter’s Five Forces Analysis

  1. Biological Drugs Market Analysis, By Product
  2. Biological Drugs Market Analysis, By Application
  3. Biological Drugs Market Analysis, By Region
  4. Competitive Overview
  5. Company Profiles

    9.1    Merck

    9.2    Amgen

    9.3    GlaxoSmithKline

    9.4    Eli Lilly and Company

    9.5    Baxter

    9.6    Abbott Laboratories

    9.7    Biogen

    9.8    Bristol-Myers Squibb Company

    9.9    Novartis

    9.10    Pfizer

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Editor Details

Related Links

Last Updated: 18-Jun-2019